Authors' Affiliations: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Princess Margaret Cancer Center, Campbell Family Institute for Breast Cancer Research, Department of Medical Biophysics, University of Toronto; Ontario Institute for Cancer Research, Ontario, Canada; Center for Comparative Medicine, University of California, Davis, Davis, California; and Department of Biochemistry, Vanderbilt University, Nashville, Tennessee.
Authors' Affiliations: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Princess Margaret Cancer Center, Campbell Family Institute for Breast Cancer Research, Department of Medical Biophysics, University of Toronto; Ontario Institute for Cancer Research, Ontario, Canada; Center for Comparative Medicine, University of California, Davis, Davis, California; and Department of Biochemistry, Vanderbilt University, Nashville, TennesseeAuthors' Affiliations: Cold Spring Harbor Laboratory, Cold Spring Harbor, New York; Princess Margaret Cancer Center, Campbell Family Institute for Breast Cancer Research, Department of Medical Biophysics, University of Toronto; Ontario Institute for Cancer Research, Ontario, Canada; Center for Comparative Medicine, University of California, Davis, Davis, California; and Department of Biochemistry, Vanderbilt University, Nashville, Tennessee
Cancer Res. 2014 Jun 1;74(11):3180-94. doi: 10.1158/0008-5472.CAN-13-3415. Epub 2014 Mar 24.
Scribble (SCRIB) localizes to cell-cell junctions and regulates establishment of epithelial cell polarity. Loss of expression of SCRIB functions as a tumor suppressor in Drosophila and mammals; conversely, overexpression of SCRIB promotes epithelial differentiation in mammals. Here, we report that SCRIB is frequently amplified, mRNA overexpressed, and protein is mislocalized from cell-cell junctions in human breast cancers. High levels of SCRIB mRNA are associated with poor clinical prognosis, identifying an unexpected role for SCRIB in breast cancer. We find that transgenic mice expressing a SCRIB mutant [Pro 305 to Leu (P305L)] that fails to localize to cell-cell junctions, under the control of the mouse mammary tumor virus long terminal repeat promoter, develop multifocal hyperplasia that progresses to highly pleomorphic and poorly differentiated tumors with basal characteristics. SCRIB interacts with phosphatase and tensin homolog (PTEN) and the expression of P305L, but not wild-type SCRIB, promotes an increase in PTEN levels in the cytosol. Overexpression of P305L, but not wild-type SCRIB, activates the Akt/mTOR/S6K signaling pathway. Human breast tumors overexpressing SCRIB have high levels of S6K but do not harbor mutations in PTEN or PIK3CA, identifying SCRIB amplification as a mechanism of activating PI3K signaling in tumors without mutations in PIK3CA or PTEN. Thus, we demonstrate that high levels of mislocalized SCRIB functions as a neomorph to promote mammary tumorigenesis by affecting subcellular localization of PTEN and activating an Akt/mTOR/S6kinase signaling pathway.
Scribble (SCRIB) 定位于细胞-细胞连接处,调节上皮细胞极性的建立。SCRIB 功能丧失可作为果蝇和哺乳动物中的肿瘤抑制因子;相反,SCRIB 在哺乳动物中的过表达促进上皮细胞分化。在这里,我们报告 SCRIB 在人类乳腺癌中经常扩增、mRNA 过表达并且蛋白从细胞-细胞连接处发生错误定位。高水平的 SCRIB mRNA 与不良的临床预后相关,这表明 SCRIB 在乳腺癌中具有意想不到的作用。我们发现,在受小鼠乳腺肿瘤病毒长末端重复启动子控制下,表达不能定位到细胞-细胞连接处的 SCRIB 突变体 [脯氨酸 305 突变为亮氨酸 (P305L)] 的转基因小鼠会发展成多灶性增生,进而进展为具有基底特征的高度多形性和低分化肿瘤。SCRIB 与磷酸酶和张力蛋白同源物 (PTEN) 相互作用,并且表达 P305L,但不是野生型 SCRIB,会促进 PTEN 水平在细胞质中的增加。P305L 的过表达,但不是野生型 SCRIB,会激活 Akt/mTOR/S6K 信号通路。过表达 SCRIB 的人类乳腺癌肿瘤具有高水平的 S6K,但没有 PTEN 或 PIK3CA 的突变,这表明 SCRIB 扩增是在没有 PIK3CA 或 PTEN 突变的情况下激活 PI3K 信号的机制。因此,我们证明高水平的错误定位的 SCRIB 通过影响 PTEN 的亚细胞定位并激活 Akt/mTOR/S6K 信号通路,作为一种新形态发挥作用,促进乳腺肿瘤发生。